News

On 7.2.2024, Graft-In International and REDDRESS Medical in collaboration with our local distributor – IES Medical and Dr. David Obasi Ukoha from Lone Star Global Consult Ltd group, launched ACTIGRAFT…

Graft-In International, a leader in wound care solutions, unveiled its groundbreaking ACTIGRAFT treatment on October 7, 2023 in a burns and wound conference in Ha-Long, Vietnam.  This cutting-edge product promises…

06/2023  GRAFT-IN, in cooperation with its representative IES Medical, Launches Operations in Kazakhstan and Secures Strategic Partnership with Ministry of Health [Astana, June 7, 2023] – GRAFT-IN,  is pleased to…

05/2023 Graft-In International, a leading medical technology company, is thrilled to announce the successful participation of ACTIGRAFT, its flagship product, at the recent Innovative Medical Technologies Conference held in Baku,…

07/2022 ACTIGRAFT Presentation in the government Oncologic hospital in Tashkent, full conference room with around 50 doctors and surgeons under the hospitality of the hospital’s general manager. Presentation and discussion…

06/2022 – Actigraft has received the approval of the Ministry of Health in Uzbekistan. We will start our activities soon, aiming to improving life quality for those suffering from diabetic…

04/2022 An innovative wound care system to help the wounded, has arrived in Ukraine – Thanks to the collaboration between RedDress, a Florida-based Medical Company, Graft-In, a Cypriot medical marketing…

03/2022 – Actigraft has received the approval of the Ministry of Health in Azerbaijan. We are launching the activity in hospitals and clinics countrywide.

03/2022: Graft-In took part in the WUW conference for wound in the UAE exhibition. together with the manufacturer Redders and our local distributor Imperial Middle East, the Actigraft treatment was…

02/2022 – Actigraft has received the approval of the Ministry of Health in Ukraine. SALAVAMED, our official partner there, is launching the activity in hospitals and clinics in order to…